Literature DB >> 1987533

Allergenicity of orally administered immunoglobulin preparations in food-allergic children.

J Bernhisel-Broadbent1, R H Yolken, H A Sampson.   

Abstract

Passive immunization by the oral administration of immunoglobulin preparations derived from bovine milk, chicken egg, and human sera has been proposed as a method for the prevention and treatment of enteric diseases. However, the allergenic potential of these proteins may be a factor limiting their widespread use for disease prevention. An in vitro study with sera from milk- and egg-allergic children was performed to determine whether these immunoglobulin preparations have allergenic potential. Protein extracts of milk, bovine immunoglobulin, egg white, human immune globulin, and five egg yolk antiviral immunoglobulin preparations were bound to nitrocellulose paper. These preparations were probed for specific IgE binding with sera from milk- and egg-allergic patients. Of 22 milk-hypersensitive patients, 16 had specific IgE binding against the bovine immunoglobulin preparation. Of 28 egg-allergic patients 15 had specific IgE binding against one or more of the egg yolk-derived antiviral chicken immunoglobulins. Control sera were negative against the milk and egg preparations. Western blot analysis confirmed that milk- and egg-allergic patients had IgE-specific antibodies for bovine and chicken immunoglobulin molecules. Therefore, the removal of contaminating proteins from milk and egg antibody preparations would be unlikely to eliminate their allergenic potential. In contrast, sera from milk- and egg-allergic patients displayed no detectable IgE binding to human immunoglobulin preparations. These data indicate that the administration of antibody preparations derived from bovine and chicken sources may lead to severe allergic reactions in milk- or egg-sensitized patients and to sensitization in some nonallergic individuals.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987533

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

Review 1.  Peroral immunotherapy with yolk antibodies for the prevention and treatment of enteric infections.

Authors:  D Carlander; H Kollberg; P E Wejåker; A Larsson
Journal:  Immunol Res       Date:  2000       Impact factor: 2.829

Review 2.  Oral delivery of antibodies. Future pharmacokinetic trends.

Authors:  R M Reilly; R Domingo; J Sandhu
Journal:  Clin Pharmacokinet       Date:  1997-04       Impact factor: 6.447

Review 3.  Is There a Role for the Enteral Administration of Serum-Derived Immunoglobulins in Human Gastrointestinal Disease and Pediatric Critical Care Nutrition?

Authors:  Melissa Van Arsdall; Ikram Haque; Yuying Liu; J Marc Rhoads
Journal:  Adv Nutr       Date:  2016-05-16       Impact factor: 8.701

4.  World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines.

Authors:  Alessandro Fiocchi; Jan Brozek; Holger Schünemann; Sami L Bahna; Andrea von Berg; Kirsten Beyer; Martin Bozzola; Julia Bradsher; Enrico Compalati; Motohiro Ebisawa; Maria Antonieta Guzman; Haiqi Li; Ralf G Heine; Paul Keith; Gideon Lack; Massimo Landi; Alberto Martelli; Fabienne Rancé; Hugh Sampson; Airton Stein; Luigi Terracciano; Stefan Vieths
Journal:  World Allergy Organ J       Date:  2010-04-23       Impact factor: 4.084

5.  Characterization and Safety Profile of Transfer Factors Peptides, a Nutritional Supplement for Immune System Regulation.

Authors:  Hudson Polonini; Any Elisa de Souza Schmidt Gonçalves; Eli Dijkers; Anderson de Oliveira Ferreira
Journal:  Biomolecules       Date:  2021-04-29

Review 6.  Perspectives on immunoglobulins in colostrum and milk.

Authors:  Walter L Hurley; Peter K Theil
Journal:  Nutrients       Date:  2011-04-14       Impact factor: 5.717

Review 7.  Avian IgY antibodies and their recombinant equivalents in research, diagnostics and therapy.

Authors:  Edzard Spillner; Ingke Braren; Kerstin Greunke; Henning Seismann; Simon Blank; Dion du Plessis
Journal:  Biologicals       Date:  2012-06-28       Impact factor: 1.856

8.  IgY antibodies protect against human Rotavirus induced diarrhea in the neonatal gnotobiotic piglet disease model.

Authors:  Celina G Vega; Marina Bok; Anastasia N Vlasova; Kuldeep S Chattha; Fernando M Fernández; Andrés Wigdorovitz; Viviana G Parreño; Linda J Saif
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240

Review 9.  Milk immunoglobulins for health promotion.

Authors:  Raj Mehra; Pertti Marnila; Hannu Korhonen
Journal:  Int Dairy J       Date:  2006-08-21       Impact factor: 3.032

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.